We are live on ! Find out more
MYOV

Myovant Sciences Ltd.

Delisted

MYOV was delisted on the 9th of March, 2023.

89 hedge funds and large institutions have $400M invested in Myovant Sciences Ltd. in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 28

16% less capital invested

Capital invested by funds: $475M → $400M (-$75.2M)

19% less funds holding

Funds holding: 11089 (-21)

38% less call options, than puts

Call options by funds: $5.52M | Put options by funds: $8.91M

61% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 33

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
89
Holders Change
-21
Holders Change %
-19.09%
% of All Funds
1.4%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
13
Increased
28
Reduced
28
Closed
33
Calls
$5.52M
Puts
$8.91M
Net Calls
-$3.4M
Net Calls Change
+$3.12M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
76
Deutsche Bank
Germany
$30K
FF
77
FourThought Financial
Florida
$13K
SPIA
78
Steward Partners Investment Advisory
New York
$7K
CWM
79
CarsonAllaria Wealth Management
Illinois
$5K
Bessemer Group
80
Bessemer Group
New Jersey
$4K
Carson Wealth (CWM LLC)
81
Carson Wealth (CWM LLC)
Nebraska
$4K +$1.21K +90 +44%
ACM
82
Aquatic Capital Management
Illinois
$3K -$13.4K -1,000 -83%
VRM
83
Vectors Research Management
New York
$3K
APA
84
American Portfolios Advisors
New York
$2.92K
LC
85
Lindbrook Capital
California
$2K +$670 +50 +56%
NFSG
86
Newbridge Financial Services Group
Florida
$1K
Kayne Anderson Rudnick Investment Management
87
Kayne Anderson Rudnick Investment Management
California
$1K +$1.3K +97 New
Macquarie Group
88
Macquarie Group
Australia
$37
LCM
89
Laurion Capital Management
New York
-$3.11M -200,000 Closed
Truist Financial
90
Truist Financial
North Carolina
-$2.62M -168,500 Closed
BC
91
Blackcrane Capital
Washington
-$2.17M -139,552 Closed
Schroder Investment Management Group
92
Schroder Investment Management Group
United Kingdom
-$1.24M -79,854 Closed
Marshall Wace
93
Marshall Wace
United Kingdom
-$844K -54,193 Closed
HF
94
HRT Financial
New York
-$752K -48,344 Closed
CC
95
Corton Capital
Ontario, Canada
-$420K -27,003 Closed
Invesco
96
Invesco
Georgia
-$410K -26,342 Closed
DTL
97
Dynamic Technology Lab
Singapore
-$410K -26,313 Closed
E
98
Ergoteles
New York
-$402K -25,847 Closed
VRS
99
Virginia Retirement Systems
Virginia
-$391 -25,100 Closed
IHAM
100
Integral Health Asset Management
New York
-$389K -25,000 Closed

MYOV Hedge Fund Activity: Q1 2022 in Review

89 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2022, worth a combined $400M — down 16% from $475M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of MYOV and 13 opened new positions — a net loss of 20 holders — while 28 trimmed existing stakes and 28 added.

The largest buyer was State Street, adding an estimated $6.23M. The largest seller was Bellevue Group, cutting an estimated $4.16M.

  • 89 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2022, down from 110 in Q4 2021.
  • Funds reported $400M of Myovant Sciences Ltd. stock for Q1 2022, down 16% quarter-over-quarter.
  • 13 funds opened new Myovant Sciences Ltd. positions in Q1 2022 and 33 closed out, a net change of -20 holders.
  • The largest Myovant Sciences Ltd. buyer in Q1 2022 was State Street, an estimated $6.23M added.
  • The largest Myovant Sciences Ltd. seller in Q1 2022 was Bellevue Group, an estimated $4.16M sold.

Based on aggregated 13F filings for Q1 2022.